文献速递炎症性肠病

改良克罗恩病排除饮食维持儿童克罗恩病缓解:随机对照试验

Modified Crohn's Disease Exclusion Diet Maintains Remission in Pediatric Crohn's Disease: Randomized Controlled Trial.
PubMed 文献 · Clin Gastroenterol Hepatol · 2024-12-26

这项国际多中心随机对照试验比较2周全肠内营养(EEN)后序贯克罗恩病排除饮食(CDED)+部分肠内营养(PEN)与8周EEN在轻至重度儿童克罗恩病中的效果。第14周持续无激素缓解率CDED组21/30(70%)vs EEN组16/26(61.5%),差异无统计学意义(P=.5);研究因COVID-19疫情招募不足而把握度不够。CDED组体重指数Z评分显著改善,EEN组未改善。

要点

  • 2周EEN后序贯CDED+PEN与8周EEN在第14周持续无激素缓解率无显著差异(70% vs 61.5%,P=.5)。
  • 第8周临床缓解率CDED组77% vs EEN组54%(P=.07),第24周维持缓解率60% vs 42%(P=.18)。
  • CDED组体重指数Z评分显著改善,EEN组未改善。

核心结论

  • 研究把握度不足,无法判断CDED在维持缓解方面是否优于EEN。
  • 2周EEN后序贯CDED可有效诱导克罗恩病缓解,多数CDED患者维持缓解至24周。
  • 尽管CDED组饮食限制持续24周,其体重指数Z评分仍显著改善,而EEN组未改善。

研究设计与样本

  • 国际、多中心、随机对照试验,比较2周EEN(Modulen IBD)后序贯3个阶段CDED+PEN与8周EEN后自由饮食+PEN至第24周。
  • 64例符合条件患者中56例被随机分组:CDED组30例,EEN组26例;因COVID-19疫情目标招募失败,研究把握度不足。

主要发现

  • 第14周主要终点:CDED组30例中21例(70%)vs EEN组26例中16例(61.5%)维持持续无激素缓解,差异无统计学意义(P=.5)。
  • 第8周临床缓解:CDED组30例中23例(77%)vs EEN组26例中14例(54%)(P=.07)。
  • 第24周维持临床缓解:CDED组30例中18例(60%)vs EEN组26例中11例(42%)(P=.18)。
  • 体重指数Z评分在CDED组显著改善,EEN组未改善。

局限性

  • 因COVID-19疫情目标招募失败,研究把握度不足。
  • 研究把握度不足以判断CDED在维持缓解方面是否优于EEN。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: The Crohn's disease exclusion diet (CDED) + partial enteral nutrition (PEN) is effective for inducing remission in mild-moderate Crohn's disease (CD). We assessed whether a 2-week course of exclusive enteral nutrition (EEN) followed by CDED+PEN is superior to 8 weeks of EEN in sustaining clinical remission at week 14 in mild-to-severe CD and if CDED+PEN can maintain remission to week 24. METHODS: This international, multicenter, randomized controlled trial compared 2 weeks of EEN (Modulen IBD) followed by 3 phases of the CDED+PEN (henceforth CDED) to 8 weeks of EEN, followed by PEN with free diet up to week 24 (henceforth EEN). RESULTS: Out of 64 eligible patients, 56 were randomized (target recruitment failed due to the COVID-19 pandemic, leading to an underpowered study): 30 patients to CDED and 26 to EEN. The primary endpoint at week 14 showed no significant difference between the groups, with sustained corticosteroid-free remission in 21 (70%) of 30 for CDED compared with 16 (61.5%) of 26 for EEN (P = .5). At week 8, clinical remission was achieved in 23 (77%) of 30 CDED patients vs 14 (54%) of 26 EEN patients (P = .07), and 18 (60%) of 30 CDED patients vs 11 (42%) of 26 EEN patients maintained clinical remission to week 24 (P = .18). The body mass index Z score significantly improved in the CDED group but not in the EEN group. CONCLUSIONS: The study was underpowered to show whether CDED was superior to EEN in sustaining remission. However, 2 weeks of EEN followed by CDED was effective in inducing remission in CD, with most CDED patients maintaining remission up to 24 weeks. Despite dietary restrictions for 24 weeks, the body mass index Z score improved significantly in the CDED group but not in the EEN group (NCT02843100).

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Sigall Boneh R, Navas-López VM, Hussey S, et al. Modified Crohn's Disease Exclusion Diet Maintains Remission in Pediatric Crohn's Disease: Randomized Controlled Trial. Clin Gastroenterol Hepatol. 2024. PMID: 39732356. doi:10.1016/j.cgh.2024.12.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。